Daniel H Sterman
Overview
Explore the profile of Daniel H Sterman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goggin K, Seo S, Wu B, Ivelja S, Kugler M, Chang M, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39911064
The role of dietary fiber in colon cancer prevention remains controversial. We investigated its impact on anti-tumor immunity and the gut microbiota in APCmin/+ mice infected with Enterotoxigenic Bacteroides fragilis....
2.
Yilmaz M, Rashidfarokhi M, Pollard K, Durmus N, Keserci S, Sterman D, et al.
Ann Case Rep
. 2024 Nov;
9(2).
PMID: 39568634
Objectives: The destruction of the World Trade Center (WTC) towers in New York City on September 11, 2001 (9/11), released approximately 1 million tons of pulverized particulate matter throughout southern...
3.
Azour L, Segal L, Condos R, Moore W, Landini N, Collazo D, et al.
Clin Imaging
. 2024 Oct;
115:110307.
PMID: 39383681
Objectives: To evaluate the clinical significance of low-field MRI lung opacity severity. Methods: Retrospective cross-sectional analysis of post-acute Covid-19 patients imaged with low-field MRI from 9/2020 through 9/2022, and within...
4.
Tsay J, Darawshy F, Wang C, Kwok B, Wong K, Wu B, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Sep;
33(11):1433-1444.
PMID: 39225784
Background: Risk of early-stage lung adenocarcinoma recurrence after surgical resection is significant, and the postrecurrence median survival is approximately 2 years. Currently, there are no commercially available biomarkers that predict...
5.
Hu X, Zhu B, Vokes N, Fujimoto J, Rojas Alvarez F, Heeke S, et al.
Res Sq
. 2024 May;
PMID: 38798564
Studying lung adenocarcinoma (LUAD) early carcinogenesis is challenging, primarily due to the lack of LUAD precursors specimens. We amassed multi-omics data from 213 LUAD and LUAD precursors to identify molecular...
6.
Dolgalev I, Zhou H, Murrell N, Le H, Sakellaropoulos T, Coudray N, et al.
Nat Commun
. 2023 Nov;
14(1):6764.
PMID: 37938580
Approximately 30% of early-stage lung adenocarcinoma patients present with disease progression after successful surgical resection. Despite efforts of mapping the genetic landscape, there has been limited success in discovering predictive...
7.
Chen P, Rojas F, Hu X, Serrano A, Zhu B, Chen H, et al.
Mod Pathol
. 2023 Sep;
36(12):100326.
PMID: 37678674
Recent statistics on lung cancer, including the steady decline of advanced diseases and the dramatically increasing detection of early-stage diseases and indeterminate pulmonary nodules, mark the significance of a comprehensive...
8.
Sharpe A, Reibman J, Oppenheimer B, Goldring R, Liu M, Shao Y, et al.
ERJ Open Res
. 2023 Jun;
9(3).
PMID: 37284422
Background: Isolated small airway abnormalities may be demonstrable at rest in patients with normal spirometry; however, the relationship of these abnormalities to exertional symptoms remains uncertain. This study uses an...
9.
Kwok B, Wu B, Kocak I, Sulaiman I, Schluger R, Li Y, et al.
Sci Rep
. 2023 Feb;
13(1):2229.
PMID: 36755121
Malignant pleural effusions (MPE) complicate malignancies and portend worse outcomes. MPE is comprised of various components, including immune cells, cancer cells, and cell-free DNA/RNA. There have been investigations into using...
10.
Sulaiman I, Chung M, Angel L, Tsay J, Wu B, Yeung S, et al.
Nat Microbiol
. 2021 Sep;
6(10):1245-1258.
PMID: 34465900
Respiratory failure is associated with increased mortality in COVID-19 patients. There are no validated lower airway biomarkers to predict clinical outcome. We investigated whether bacterial respiratory infections were associated with...